Skip to main content

Minerva Neurosciences, Inc.

NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001598646

No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Minerva Neurosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of NERV: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7268−4
Shares31.4M27.2M−4.18M (−13.3%)
Value$91.4M$63.2M−$28.2M (−30.9%)

New holders (15)

Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to NERV in Q2 2021
InstitutionSharesValue% of portfolio
Ergoteles LLC162,100$376.0K0.01%
Tibra Equities Europe Ltd136,100$316.0K0.10%
HRT Financial LP98,944$229.0K0.00%
Jump Financial, LLC65,600$153.0K0.01%
XTX Topco Ltd34,202$79.0K0.03%
LMR Partners LLP31,189$72.0K0.00%
Dynamic Technology Lab Private Ltd17,575$41.0K0.00%
Virtu Financial LLC15,389$36.0K0.00%
Squarepoint Ops LLC15,578$36.0K0.00%
Qube Research & Technologies Ltd15,329$36.0K0.00%
Y-Intercept (Hong Kong) Ltd10,126$23.0K0.01%
Pinz Capital Management, LP7,900$18.0K0.01%
Captrust Financial Advisors4,000$9.00K0.00%
Advisory Services Network, LLC1,000$2.00K0.00%
State of Wyoming98$00.00%

Sold out (19)

Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.